News
Pharmacy & healthcare news
Industry updates, regulation, and developments that matter to Indian pharmacies.

Early Use of Statin–Ezetimibe Combo Could Prevent Thousands of Heart Attacks, Study Finds
A new study by Lund University and Imperial College London reveals that initiating a combination of statins and ezetimibe in patients recovering from myocardial infarction (MI) could significantly reduce recurrent heart attacks and cardiovascular deaths.
Apr 15, 2025

Eli Lilly's Mounjaro Launch in India Triggers Surge in Weight-Loss Enquiries
The Indian launch of Eli Lilly's weight-loss medication Mounjaro has created a tidal wave of patient interest, with some clinics and physicians reporting scores of enquiries within day
Apr 15, 2025

FDA Warns of Counterfeit Ozempic in U.S. Supply Chain Amid Rising Demand
The U.S. Food and Drug Administration (FDA) has issued a warning about counterfeit Ozempic 1mg injections circulating through unauthorized distributors.
Apr 15, 2025

Woxsen University Unveils AI-Driven Necrobotic System for Sustainable, Precision Robotic Surgery
Woxsen University’s AI Research Centre in Telangana has developed an AI-powered necrobotic surgical system that combines biologically sourced materials with real-time machine learning to deliver highly precise, minimally invasive surgical interventions.
Apr 14, 2025

Zydus Receives US FDA Approval for Deflazacort to Treat Duchenne Muscular Dystrophy
Zydus Lifesciences has secured final approval from the US Food and Drug Administration (US FDA) for its corticosteroid drug Jaythari (Deflazacort), a therapeutic option for Duchenne muscular dystrophy (DMD) in patients aged 5 years and above.
Apr 14, 2025

Delhi Chemist Association Warns Public Amid Rising Fake Medicine Cases
Amid repeated seizures of fake drugs across Delhi, the Retail Distributor and Chemist Alliance (RDCA) has urged citizens to follow strict precautions while purchasing medicines.
Apr 13, 2025

FDI Inflows Into Indian Pharma Sector Cross ₹19,134 Crore in FY 2024–25
India’s pharmaceutical and medical devices sector witnessed robust foreign direct investment (FDI) activity in FY 2024–25, surpassing ₹19,134 crore in total inflows.
Apr 13, 2025

Fake Cosmetics and Medicines Worth ₹1.20 Crore Seized in Bareilly; One Arrested
In a major crackdown on counterfeit products, Bareilly police seized fake cosmetics and allopathic goods worth approximately ₹1.20 crore and arrested a man for selling expired products with forged expiry dates and labels.
Apr 12, 2025

Cipla Gets US FDA Approval for Cancer Generic Drug Paclitaxel
Cipla has received final approval from the US Food and Drug Administration (US FDA) for its Protein-bound Paclitaxel, a generic version of the cancer drug Abraxane.
Apr 11, 2025

Experts Raise Concerns Over Eli Lilly’s Promotional Strategies for Mounjaro in India
As Eli Lilly launches its blockbuster diabetes and weight-loss medication Mounjaro (tirzepatide) in India, experts have expressed serious alarm over the company's marketing practices. Complaints point towards possible Indian drug advertising law violations, particularly direct-to-consumer promotion.
Apr 11, 2025

GC Biopharma Receives Approval for World's First Recombinant Anthrax Vaccine BARYTHRAX
GC Biopharma, in partnership with Korea Disease Control and Prevention Agency (KDCA), has gained regulatory approval from Korea's Ministry of Food and Drug Safety (MFDS) for BARYTHRAX—world's first recombinant protein anthrax vaccine. This is Korea's 39th new drug and a milestone in biodefense readiness.
Apr 11, 2025

RRI Scientists Develop Affordable Device for Early Screening of Sickle Cell Disease
In a glimmer of hope for affordable diagnostics, researchers at Bengaluru's Raman Research Institute (RRI) have created a low-cost electro-fluidic micropore device for initial screening of Sickle Cell Disease (SCD).
Apr 11, 2025

Antibiotics Identified As Leading Cause Of Drug Side Effects In National Survey
A nationwide survey has recently indicated that antibiotics are the most common cause of drug-related side effects among Indians. Carried out across 303 districts with responses from more than 17,000 citizens, the study indicates extensive over-the-counter sale and misuse of antibiotics as the most critical public health issue.
Apr 10, 2025

Gujarat FDCA Uncovers Fake QR Codes on Top Medicine Brand, Launches Statewide Crackdown
The Gujarat Food and Drug Control Administration (FDCA) has revealed spurious QR codes on a well-known pharma brand's medicine, leading to a widescale investigation and enforcement crackdown to ensure drug supply chain integrity.
Apr 10, 2025

Akums Launches India’s First Ripasudil+Timolol Combo for Glaucoma and Ocular Hypertension
Akums Drugs & Pharmaceuticals has launched a novel combination therapy of ripasudil and timolol for managing glaucoma and ocular hypertension.
Apr 1, 2025

Three Lotion Brands Fined for Misleading 'Skin Whitening in Minutes' Claims
The Central Consumer Protection Authority (CCPA) has penalised three lotion manufacturers for falsely advertising instant skin whitening effects.
Apr 1, 2025

US FDA Approves Freeze-Dried Formulation of Bavarian Nordic’s Mpox and Smallpox Vaccine
In a move aimed at improving vaccine stockpiling capabilities, the U.S. FDA has approved a freeze-dried version of Bavarian Nordic’s mpox and smallpox vaccine, Jynneos.
Apr 1, 2025

WHO Releases First-Ever Reports on Testing and Treatment Gaps for Fungal Infections
The World Health Organization (WHO) has published its first ever reports on diagnostic and treatment gaps in the treatment of invasive fungal infections.
Apr 1, 2025
Ready to simplify your pharmacy?
Start your free 7-day trial or book a personalised demo today.